[{"Assets_0_Q1_USD":129285000000.0,"CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q1_USD":0.45,"Country":"United States","EarningsPerShareBasic_1_Q1_USD":-0.34,"EarningsPerShareDiluted_1_Q1_USD":-0.34,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162365000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":3894000000.0,"NetIncomeLossConverted_1_Q1_USD":-775000000.0,"OfficialName":"Bristol-Myers Squibb Company Common Stock","RevenuesConverted_1_Q1_USD":10781000000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":49977000000.0,"StockholdersEquity_0_Q1_USD":49911000000.0,"Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":2258000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":2258000000.0,"filed":"20200507","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2020.0","name":"BRISTOL MYERS SQUIBB CO","period":"20200331","qtrs":"0","uom":"USD"}]